欢迎来到360期刊网!
学术期刊
  • 学术期刊
  • 文献
  • 百科
电话
您当前的位置:

首页 > NSFC查询> 肥胖症发病机制

项目名称

肥胖症发病机制

学科学类

H07 医学科学部_内分泌系统/代谢和营养支持

项目批准号

81522011

资助类型

优秀青年科学基金项目

资助经费

130万元

项目负责人

王计秋

职称

副研究员

批准年份

2015

单位名称

上海交通大学

起止时间

2016-01至2018-12

项目中文摘要

申请人长期致力于肥胖症发病机制研究。组建肥胖课题组,建立完善的、高质量肥胖研究平台,包括中国早发性肥胖研究队列(GOCY)、能量代谢基础研究系列平台以及多种基因修饰小鼠模型。基于队列二代测序,原创性发现LGR4激活变异显著增加肥胖发生风险,借助动物模型揭示LGR4通过调节白色脂肪棕色化参与肥胖发生的机制。发现新肥胖候选致病基因TUT1和NPC1,揭示其低频变异导致肥胖发生的机制。并开展肥胖相关代谢紊乱研究,揭示LGR4 通过调控醛固酮受体途径调节水盐代谢和血压的分子机制,发现LGR4调控脂代谢节律等。以第一或通讯作者在Nat Cell Biol、JASN、JME等期刊发表成果。本项目拟延续前期工作,结合临床队列与动物模型深入探讨LGR4配体RSPO1在米色脂肪分化与体重调节中的作用,阐明RSPO1/LGR4通过经典Wnt通路调控肥胖发生的机制,为减重药物开发提供新靶点,促进临床转化。

项目英文摘要

The applicant has been engaged in the exploration of the mechanisms of obesity and intervention targets for obesity. Under his leadership, the research group systematically conducted the screening of candidate genes for obesity and further validation with functional study. They found a functional variant of LGR4 gene in a Chinese obese-control study, which significantly increases the risk for human obesity. By analyzing Lgr4 gene knockout mice, they demonstrate that LGR4 promotes energy accumulation and obesity by inhibiting beige adipocyte differentiation through regulating Rb1 expression. They also identified low-frequency variants of NPC1 gene, which dramatically increase the risk for human obesity by 9 folds, and demonstrated NPC1 hypoinsufficiency promotes body weight gain in mice. The research group also conducted studies of the molecular mechanism of obesity-related metabolic syndrome. They found that LGR4 regulates blood pressure by mineralocorticoid receptor signaling pathway. Besides, they first reported the role of LGR4 in regulating plasma lipid rhythms. Based on these major findings, the applicant has published 5 representative papers in high-quality journals on medical science, Nature Cell Biology, Journal of the American Society of Nephrology and Journal of Molecular Endocrinology as first or corresponding author. The total impact factors of the 5 publications are 40.58 and the highest one is 20.06. The applicant has 9 SCI publications in total, which were cited 35+ times by others. This project aims (1) to study the role of the potential LGR4 ligand, RSPO1 in adipocyte differentiation and body weight regulation using gene knockout mouse models; (2) to demonstrate the molecular mechanisms of RSPO1/LGR4/Wnt signaling in regulating beige adipocyte differentiation and obesity. This will not only provide evidence for understanding the mechanisms for obesity, but also provide potential intervention targets for obesity.

结题摘要

在此项目资助下,负责人带领团队严格按照项目计划方案,在前期研究基础上继续深入探索,结合临床与基础研究,在肥胖症发病机制(致病基因、棕色脂肪关键调控因子、肠道菌群等)方向取得一定成绩,尤其是围绕“RSPO1-LGR4-Wnt/β-Catenin”信号通路,原创性的提出了肥胖症防治的全新靶点;初步完成国内最大规模青少年重度肥胖队列的全外显子遗传分析工作。代表性成果发表于Nature Medicine、Diabetes、EBioMedicine、Obesity等杂志。申请人先后入选教育部长江学者奖励计划(青年,2018)、上海市卫生系统优秀学科带头人(2018)、上海市拔尖人才(2016)、中源协和生命科学创新突破奖(2016)等人才奖励计划。

评审程序详情
接收申请书
(3月15日前)
3月5日基金委协助
各申请单位查重
基金委初筛
(4月30日前)

97%

25%

15%

同行专家评议(5月份)
(3-5个同行评议专家)
项目主任分析归类
评审意见表(6-7月份)
公布并接受
复查申请
重点项目、杰青、
优青答辩
发正式资助通知
(9月底-11月初)
委员会审批
(9月份)
学科评审组会议
(7月底-8月初)

360期刊网

专注医学期刊服务15年

  • 您好:请问您咨询什么等级的期刊?专注医学类期刊发表15年口碑企业,为您提供以下服务:

  • 1.医学核心期刊发表-全流程服务
    2.医学SCI期刊-全流程服务
    3.论文投稿服务-快速报价
    4.期刊推荐直至录用,不成功不收费

  • 客服正在输入...

x
立即咨询